1.44% -0.11

Fennec Pharmaceuticals Inc (FENC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Fennec Pharmaceuticals Inc Azioni (FENC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	29.11% 12.46	9.652	8.751	7.925	6.974
Operating Expenses	2.16% 12.65	12.38	9.559	8.859	12.18
Benefits Costs and Expenses	-	-	9.916	9.545	-
Costs And Expenses	2.16% 12.65	12.38	9.916	9.545	12.18
Operating Income/Loss	93.08% -0.189	-2.732	-0.808	-0.934	-5.202
Nonoperating Income/Loss	6.90% -0.449	-0.42	-0.357	-0.686	-0.533
Income/Loss From Continuing Operations Before Tax	495.37% 12.46	-3.152	-1.165	-1.62	6.974
Income/Loss From Continuing Operations After Tax	79.76% -0.638	-3.152	-1.165	-1.985	-5.735
Net Income/Loss	79.76% -0.638	-3.152	-1.165	-1.985	-5.735
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.81% 27.89	27.66	27.58	-0.077	27.37
Diluted Average Shares	0.81% 27.89	27.66	27.58	-0.721	27.37
Basic Earnings Per Share	81.82% -0.02	-0.11	-0.04	-0.08	-0.21
Diluted Earnings Per Share	81.82% -0.02	-0.11	-0.04	-0.08	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%